CTKB
Cytek Biosciences Inc
5.70$
+8.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -23.7% | 16.3% | 3.6% | -7.5% | 2.7% | 12.7% | -2.3% | |
| 0.5% | 0.6% | 1.0% | 3.4% | 4.8% | 5.2% | 5.9% | |
| 0.5% | 0.7% | 5.1% | 10.1% | 11.4% | 13.4% | 12.2% | |
| 2.8% | 2.9% | 5.5% | 10.6% | – | – | – | |
| 2.0% | -8.1% | -6.8% | -24.3% | -5.4% | 3.8% | -2.4% | |
| 1.7% | 1.7% | 3.4% | 6.0% | 2.5% | 1.8% | 2.0% | |
| -1.7% | -1.7% | -16.4% | -34.1% | -48.6% | -41.4% | 5.0% | |
| – | – | – | 0.1% | 0.8% | – | – | |
| – | – | 169.1% | -0.1% | -22.9% | -10.8% | -7.5% | |
| 4.8% | 3.0% | -2.2% | 1.8% | -0.3% | 1.8% | 0.4% | |
| 0.2% | 132.1% | 166.9% | 3.4% | -21.7% | -7.9% | -6.7% | |
| -25.3% | 146.1% | 155.1% | -39.7% | -68.3% | -34.4% | -3.9% | |
| -25.4% | 14.7% | 0.2% | -13.5% | 0.2% | 10.9% | -4.4% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.